|
2022-03-16 |
2022-03-15 |
PS
Planned sale
|
Kiraly Thomas E
EVP & Chief Financial Officer
Officer
|
8,750
-3.3%
19.16
USD 167,611
|
8,750
-3.3%
|
19.16
|
USD 167,611
|
|
|
2022-03-08 |
2022-03-08 |
S
Sale
|
Campbell James H
SVP, Chief Clinical Officer
Officer
|
4,000
-7.5%
19.52
USD 78,082
|
4,000
-7.5%
|
19.52
|
USD 78,082
|
|
|
2021-12-17 |
2021-12-16 |
PS
Planned sale
|
Kiraly Thomas E
EVP & Chief Financial Officer
Officer
|
8,750
-3.5%
17.30
USD 151,362
|
8,750
-3.5%
|
17.30
|
USD 151,362
|
|
|
2021-09-17 |
2021-09-16 |
PS
Planned sale
|
Kiraly Thomas E
EVP & Chief Financial Officer
Officer
|
8,750
-3.4%
21.86
USD 191,307
|
8,750
-3.4%
|
21.86
|
USD 191,307
|
|
|
2021-06-08 |
2021-06-07 |
PS
Planned sale
|
ASAR VINIT K
President and CEO
Executive Director
|
15,000
-1.9%
25.86
USD 387,956
|
15,000
-1.9%
|
25.86
|
USD 387,956
|
|
|
2021-05-04 |
2021-04-30 |
PS
Planned sale
|
Adams Gabrielle B.
Vice President Accounting
Officer
|
20,938
-25.9%
25.03
USD 523,988
|
20,938
-25.9%
|
25.03
|
USD 523,988
|
|
|
2021-03-17 |
2021-03-16 |
PS
Planned sale
|
Kiraly Thomas E
EVP & Chief Financial Officer
Officer
|
8,750
-3.2%
23.93
USD 209,381
|
8,750
-3.2%
|
23.93
|
USD 209,381
|
|
|
2021-03-11 |
2021-03-10 |
PS
Planned sale
|
ASAR VINIT K
President and CEO
Executive Director
|
15,000
-1.9%
23.22
USD 348,281
|
15,000
-1.9%
|
23.22
|
USD 348,281
|
|
|
2019-12-10 |
2019-12-06 |
S
Sale
|
Adams Gabrielle B.
Vice President Accounting
Officer
|
10,000
-20.2%
26.81
USD 268,129
|
10,000
-20.2%
|
26.81
|
USD 268,129
|
|
|
2019-11-18 |
2019-11-18 |
S
Sale
|
Wendt Jay C
President, Products & Services
Officer
|
5,000
-12.4%
24.00
USD 120,000
|
5,000
-12.4%
|
24.00
|
USD 120,000
|
|
|
2019-11-18 |
2019-11-18 |
S
Sale
|
Wendt Jay C
President, Products & Services
Officer
|
5,000
-11.0%
23.95
USD 119,769
|
5,000
-11.0%
|
23.95
|
USD 119,769
|
|
|
2019-11-18 |
2019-11-18 |
S
Sale
|
Wendt Jay C
President, Products & Services
Officer
|
5,000
-9.9%
23.92
USD 119,591
|
5,000
-9.9%
|
23.92
|
USD 119,591
|
|
|
2019-11-18 |
2019-11-18 |
S
Sale
|
Wendt Jay C
President, Products & Services
Officer
|
4,825
-8.8%
23.87
USD 115,181
|
4,825
-8.8%
|
23.87
|
USD 115,181
|
|
|
2019-11-12 |
2019-11-11 |
S
Sale
|
Campbell James H
SVP, Chief Clinical Officer
Officer
|
2,925
-12.7%
23.81
USD 69,643
|
2,925
-12.7%
|
23.81
|
USD 69,643
|
|
|
2019-08-12 |
2019-08-09 |
S
Sale
|
Wendt Jay C
President, Products & Services
Officer
|
2,860
-7.4%
19.43
USD 55,580
|
2,860
-7.4%
|
19.43
|
USD 55,580
|
|
|
2019-05-13 |
2019-05-10 |
B
Purchase
|
ASAR VINIT K
President and CEO
Executive Director
|
2,700
+0.5%
18.98
USD 51,243
|
2,700
+0.5%
|
18.98
|
USD 51,243
|
|
|
2018-11-14 |
2018-11-13 |
S
Sale
|
Hartman Thomas E
SVP and General Counsel
Officer
|
3,800
-6.3%
19.67
USD 74,758
|
3,800
-6.3%
|
19.67
|
USD 74,758
|
|
|
2018-11-14 |
2018-11-12 |
S
Sale
|
Hartman Thomas E
SVP and General Counsel
Officer
|
2,200
-3.5%
20.26
USD 44,579
|
2,200
-3.5%
|
20.26
|
USD 44,579
|
|
|
2014-08-26 |
2014-08-25 |
B
Purchase
|
HARE STEPHEN E
Non-Executive Director
|
1,000
+2.6%
21.98
USD 21,980
|
1,000
+2.6%
|
21.98
|
USD 21,980
|
|
|
2014-08-20 |
2014-08-19 |
B
Purchase
|
PETTINGILL RICHARD
Non-Executive Director
|
4,810
+87.9%
20.79
USD 99,980
|
4,810
+87.9%
|
20.79
|
USD 99,980
|
|
